Published On: Mon, Sep 12th, 2016

Recent Research Analysts’ Ratings Changes for Walgreens Boots Alliance (WBA)

Several analysts have recently updated their ratings and price targets for Walgreens Boots Alliance (NASDAQ: WBA):

9/10/2016 – Walgreens Boots Alliance had its “outperform” rating reaffirmed by analysts at Robert W. Baird. They now have a $95.00 price target on the stock.
9/9/2016 – Walgreens Boots Alliance had its “buy” rating reaffirmed by analysts at Deutsche Bank AG. They now have a $94.00 price target on the stock.
9/1/2016 – Walgreens Boots Alliance had its “outperform” rating reaffirmed by analysts at Credit Suisse Group AG. They now have a $95.00 price target on the stock, up previously from $80.71.
8/30/2016 – Walgreens Boots Alliance had its “outperform” rating reaffirmed by analysts at Leerink Swann.
8/30/2016 – Walgreens Boots Alliance had its price target raised by analysts at Deutsche Bank AG from $93.00 to $94.00. They now have a “buy” rating on the stock.
8/30/2016 – Walgreens Boots Alliance had its “buy” rating reaffirmed by analysts at Bank of America Corp.. They now have a $94.00 price target on the stock.
7/22/2016 – Walgreens Boots Alliance had its “underperform” rating reaffirmed by analysts at Keefe, Bruyette & Woods.
7/18/2016 – Walgreens Boots Alliance had its “buy” rating reaffirmed by analysts at Credit Suisse Group AG. They now have a $82.51 price target on the stock, down previously from $95.00.
7/18/2016 – Walgreens Boots Alliance had its “buy” rating reaffirmed by analysts at Deutsche Bank AG.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at 82.92 on Monday. The company has a 50-day moving average price of $81.40 and a 200-day moving average price of $81.14. Walgreens Boots Alliance Inc has a one year low of $71.50 and a one year high of $95.74. The company has a market capitalization of $89.75 billion, a price-to-earnings ratio of 28.65 and a beta of 1.01.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, July 6th. The pharmacy operator reported $1.18 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.14 by $0.04. The company had revenue of $29.50 billion for the quarter. Walgreens Boots Alliance had a return on equity of 15.56% and a net margin of 2.70%. The company’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.02 earnings per share. Equities research analysts anticipate that Walgreens Boots Alliance Inc will post $4.51 EPS for the current year.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/12/recent-research-analysts-ratings-changes-for-walgreens-boots-alliance-wba.html

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 12th. Stockholders of record on Friday, August 19th will be given a $0.375 dividend. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. This represents a $1.50 annualized dividend and a dividend yield of 1.81%. The ex-dividend date is Wednesday, August 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 51.90%.
In related news, EVP Kathleen Wilson-Thompson sold 29,695 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $83.00, for a total transaction of $2,464,685.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William C. Foote sold 2,067 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $81.35, for a total value of $168,150.45. Following the sale, the director now directly owns 26,690 shares in the company, valued at $2,171,231.50. The disclosure for this sale can be found here. 21.10% of the stock is owned by insiders.
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>